Top compounds associated with response to USP17L8


Feature Type Standardized
Nominal ANOVA
mRNA AZ-3146 CTRPv2 pan-cancer AAC -0.056 0.1
mRNA Erlotinib UHNBreast pan-cancer AAC 0.45 0.1
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.059 0.1
mRNA BRD-K84807411 CTRPv2 pan-cancer AAC -0.11 0.1
mRNA AZD0530 CTRPv2 pan-cancer AAC -0.057 0.1
mRNA NVP-231 CTRPv2 pan-cancer AAC -0.05 0.1
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.055 0.1
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.054 0.1
mRNA BRD1835 CTRPv2 pan-cancer AAC 0.057 0.1
mRNA lapatinib CTRPv2 pan-cancer AAC -0.054 0.1
Download CSV